Literature DB >> 31778323

Public resources for chemical probes: the journey so far and the road ahead.

Albert A Antolin1,2,3, Paul Workman2,3, Bissan Al-Lazikani1,2,3.   

Abstract

High-quality small molecule chemical probes are extremely valuable for biological research and target validation. However, frequent use of flawed small-molecule inhibitors produces misleading results and diminishes the robustness of biomedical research. Several public resources are available to facilitate assessment and selection of better chemical probes for specific protein targets. Here, we review chemical probe resources, discuss their current strengths and limitations, and make recommendations for further improvements. Expert review resources provide in-depth analysis but currently cover only a limited portion of the liganded proteome. Computational resources encompass more proteins and are regularly updated, but have limitations in data availability and curation. We show how biomedical scientists may use these resources to choose the best available chemical probes for their research.

Keywords:  chemical biology; chemical probes; chemical tools; protein targets; resources

Year:  2019        PMID: 31778323     DOI: 10.4155/fmc-2019-0231

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  4 in total

1.  A conversation on using chemical probes to study protein function in cells and organisms.

Authors: 
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

2.  Target 2035 - update on the quest for a probe for every protein.

Authors:  Susanne Müller; Suzanne Ackloo; Arij Al Chawaf; Bissan Al-Lazikani; Albert Antolin; Jonathan B Baell; Hartmut Beck; Shaunna Beedie; Ulrich A K Betz; Gustavo Arruda Bezerra; Paul E Brennan; David Brown; Peter J Brown; Alex N Bullock; Adrian J Carter; Apirat Chaikuad; Mathilde Chaineau; Alessio Ciulli; Ian Collins; Jan Dreher; David Drewry; Kristina Edfeldt; Aled M Edwards; Ursula Egner; Stephen V Frye; Stephen M Fuchs; Matthew D Hall; Ingo V Hartung; Alexander Hillisch; Stephen H Hitchcock; Evert Homan; Natarajan Kannan; James R Kiefer; Stefan Knapp; Milka Kostic; Stefan Kubicek; Andrew R Leach; Sven Lindemann; Brian D Marsden; Hisanori Matsui; Jordan L Meier; Daniel Merk; Maurice Michel; Maxwell R Morgan; Anke Mueller-Fahrnow; Dafydd R Owen; Benjamin G Perry; Saul H Rosenberg; Kumar Singh Saikatendu; Matthieu Schapira; Cora Scholten; Sujata Sharma; Anton Simeonov; Michael Sundström; Giulio Superti-Furga; Matthew H Todd; Claudia Tredup; Masoud Vedadi; Frank von Delft; Timothy M Willson; Georg E Winter; Paul Workman; Cheryl H Arrowsmith
Journal:  RSC Med Chem       Date:  2021-12-03

3.  PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells.

Authors:  Susanne Prokop; Péter Ábrányi-Balogh; György M Keserű; Benjámin Barti; Márton Vámosi; Miklós Zöldi; László Barna; Gabriella M Urbán; András Dávid Tóth; Barna Dudok; Attila Egyed; Hui Deng; Gian Marco Leggio; László Hunyady; Mario van der Stelt; István Katona
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

4.  canSAR: update to the cancer translational research and drug discovery knowledgebase.

Authors:  Costas Mitsopoulos; Patrizio Di Micco; Eloy Villasclaras Fernandez; Daniela Dolciami; Esty Holt; Ioan L Mica; Elizabeth A Coker; Joseph E Tym; James Campbell; Ka Hing Che; Bugra Ozer; Christos Kannas; Albert A Antolin; Paul Workman; Bissan Al-Lazikani
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.